RaQualia Pharma Inc.
4579.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥3,141,929 | ¥3,714,984 | ¥3,675,450 | ¥2,345,306 |
| Short-Term Investments | ¥199,999 | ¥49,754 | ¥250,599 | ¥313,807 |
| Receivables | ¥689,162 | ¥603,196 | ¥602,311 | ¥1,205,401 |
| Inventory | ¥167,722 | ¥147,939 | ¥8,500 | ¥10,547 |
| Other Curr. Assets | ¥146,561 | ¥186,293 | ¥86,781 | ¥22,393 |
| Total Curr. Assets | ¥4,538,963 | ¥4,956,894 | ¥4,822,094 | ¥4,003,775 |
| Property Plant & Equip (Net) | ¥529,082 | ¥573,608 | ¥391,024 | ¥299,389 |
| Goodwill | ¥3,865,297 | ¥0 | ¥0 | ¥0 |
| Intangibles | ¥36,979 | ¥30,187 | ¥24,325 | ¥33,799 |
| Long-Term Investments | ¥547,053 | ¥1,231,458 | ¥737,363 | ¥574,125 |
| Tax Assets | ¥78,460 | ¥0 | -¥737,363 | ¥313,947 |
| Other NC Assets | ¥59,648 | ¥79,822 | ¥1,020,207 | ¥9,160 |
| Total NC Assets | ¥5,116,519 | ¥1,915,075 | ¥1,435,556 | ¥1,230,420 |
| Other Assets | ¥2 | ¥3 | ¥3 | ¥2 |
| Total Assets | ¥9,655,482 | ¥6,871,972 | ¥6,257,653 | ¥5,234,197 |
| Liabilities | – | – | – | – |
| Payables | ¥59,317 | ¥54,174 | ¥128,066 | ¥45,996 |
| Short-Term Debt | ¥512,620 | ¥12,620 | ¥2,620 | ¥21,547 |
| Tax Payable | ¥28,044 | ¥19,687 | ¥30,957 | ¥117,880 |
| Deferred Revenue | ¥0 | ¥0 | ¥0 | ¥293,652 |
| Other Curr. Liab. | ¥545,901 | ¥238,531 | ¥289,248 | -¥62,623 |
| Total Curr. Liab. | ¥1,187,495 | ¥389,313 | ¥493,778 | ¥400,524 |
| LT Debt | ¥2,651,430 | ¥39,050 | ¥9,170 | ¥0 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥0 | ¥12,129 |
| Deferred Tax Liab, NC | ¥0 | ¥58,303 | ¥2,750 | ¥16,018 |
| Other NC Liab. | ¥27,420 | ¥71,420 | ¥87,314 | ¥12,133 |
| Total NC Liab. | ¥2,897,477 | ¥363,000 | ¥266,895 | ¥45,671 |
| Other Liabilities | ¥0 | -¥313 | ¥0 | ¥0 |
| Cap. Leases | ¥288,284 | ¥316,048 | ¥210,548 | ¥39,067 |
| Total Liabilities | ¥4,084,972 | ¥752,000 | ¥760,673 | ¥446,195 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥24 | ¥0 | ¥0 |
| Common Stock | ¥2,720,540 | ¥2,667,649 | ¥2,265,697 | ¥2,256,920 |
| Retained Earnings | -¥45,673 | ¥449,358 | ¥773,021 | ¥49,631 |
| AOCI | -¥14,578 | ¥146,000 | ¥2,803 | ¥34,769 |
| Other Equity | ¥0 | ¥1 | ¥0 | ¥0 |
| Total Equity | ¥5,570,510 | ¥6,120,442 | ¥5,496,980 | ¥4,788,002 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥9,655,482 | ¥6,871,972 | ¥6,257,653 | ¥5,234,197 |
| Net Debt | ¥22,121 | -¥3,663,314 | -¥3,663,660 | -¥2,323,759 |